Last $17.19 USD
Change Today -0.57 / -3.21%
Volume 190.7K
THRX On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 10:57 AM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Leonard M. Blum

Chief Commercial Officer and Senior Vice President, Theravance Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

53$777,390
As of Fiscal Year 2013

Background*

Mr. Leonard M. Blum has been the Chief Commercial Officer and Senior Vice President of Theravance Inc. since July 31, 2007. Mr. Blum has over 20 years of marketing and sales leadership experience in the biotechnology and pharmaceutical industries. Prior to Theravance, he served as Senior Vice President, Sales & Marketing of ICOS Corporation from May 2005 till July 2007. He joined ICOS as Vice President, Marketing in June 2000 and served as its Vice President, Sales & ...

Read Full Background

Corporate Headquarters*

901 Gateway Boulevard
South San Francisco, California 94080

United States

Phone: 650-238-9600
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Princeton University
MBA
The Leland Stanford Junior University

Other Affiliations*

Annual Compensation*

Salary$415,740
Bonus$41,674
Total Annual Compensation$457,414

Stock Options*

Restricted Stock Awards$111,100
All Other Compensation$500
Exercisable Options205,000
Exercisable Options Value$2,253,250
Total Value of Options$2,253,250
Total Number of Options205,000

Total Compensation*

Total Annual Cash Compensation$666,290
Total Short Term Compensation$457,414
Other Long Term Compensation$111,600
Total Calculated Compensation$777,390
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THRX:US $17.21 USD -0.55

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Richard Martin Steeves BSc., Ph.D.Group Chief Executive Officer, Member of Senior Executive Board and Executive Director
Synergy Health plc
823.0K GBP
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAVANCE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.